These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16124142)

  • 21. On call. In your January 2007 article on cholesterol, you said that no-flush niacin does not lower cholesterol levels. But my problem is low HDL cholesterol. Will no-flush niacin help my HDL even if it won't lower my LDL cholesterol?
    Simon HB
    Harv Mens Health Watch; 2007 Jun; 11(11):7-8. PubMed ID: 17644843
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lower LDL and/or raise HDL. In what direction is lipidology moving?].
    Parhofer KG
    MMW Fortschr Med; 2007 May; 149(22):27. PubMed ID: 18069222
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetics and molecular biology: rationale for targeting high-density lipoprotein cholesterol for therapeutic intervention.
    Mukherjee S
    Curr Opin Lipidol; 2006 Oct; 17(5):602-5. PubMed ID: 16960508
    [No Abstract]   [Full Text] [Related]  

  • 24. Current world literature.
    Curr Opin Lipidol; 2009 Dec; 20(6):512-9. PubMed ID: 19935200
    [No Abstract]   [Full Text] [Related]  

  • 25. What is non-HDL cholesterol?
    Johns Hopkins Med Lett Health After 50; 2009 Jul; 21(5):8. PubMed ID: 19630123
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hypolipidemic drugs and diabetes mellitus].
    Bláha V; Mistrík E
    Vnitr Lek; 2009 Apr; 55(4):357-62. PubMed ID: 19449750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel therapies for increasing serum levels of HDL.
    Toth PP
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):151-70. PubMed ID: 19217517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
    Carlson LA
    Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
    [No Abstract]   [Full Text] [Related]  

  • 29. Powerful HDL booster available OTC.
    Health News; 2005 Apr; 11(4):5. PubMed ID: 15818764
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of high-risk older persons with lipid-lowering drug therapy.
    Aronow WS
    Am J Ther; 2008; 15(2):102-7. PubMed ID: 18356628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P
    Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular screening and HDL cholesterol.
    Piwinski SE
    Aviat Space Environ Med; 1994 Sep; 65(9):878. PubMed ID: 7818460
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipids for psychiatrists - an overview.
    Young IS
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):66-75. PubMed ID: 16280339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug treatment of hypercholesterolaemia. Review criteria for cholesterol tests.
    Lough M
    BMJ; 1994 Jan; 308(6920):56-7. PubMed ID: 8155130
    [No Abstract]   [Full Text] [Related]  

  • 35. Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes.
    Maahs DM; Wadwa RP; McFann K; Nadeau K; Williams MR; Eckel RH; Klingensmith GJ
    J Pediatr; 2007 Feb; 150(2):146-50, 150.e1-2. PubMed ID: 17236891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of apolipoproteins: An important tool for prevention and treatment of cardiovascular diseases].
    Wiklund O
    Lakartidningen; 2007 May 14-29; 104(20-21):1623-4. PubMed ID: 17564272
    [No Abstract]   [Full Text] [Related]  

  • 37. Unexpected and abnormally low HDL cholesterol levels on combination hypolipidemic therapy.
    Unnikrishnan R; Das R; Jaydip R; Sudhakaran C; Mohan V
    J Assoc Physicians India; 2009 Feb; 57():180-1. PubMed ID: 19582991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bibliography. Current world literature. Clinical trials.
    Curr Opin Cardiol; 2008 Jul; 23(4):407-21. PubMed ID: 18520727
    [No Abstract]   [Full Text] [Related]  

  • 39. Levels of dyslipidaemia and improvement in its management in England: results from the Health Survey for England 2003.
    Primatesta P; Poulter NR
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):292-8. PubMed ID: 16487439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential for CETP inhibition to reduce cardiovascular disease risk.
    Ansell B; Hobbs FD
    Curr Med Res Opin; 2006 Dec; 22(12):2467-78. PubMed ID: 17257461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.